-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Inflammatory bowel disease (IBD) consisting of Crohn's disease (CD) and ulcerative colitis (UC) may be complicated by the presence of extraintestinal manifestations (EIM)
.
EIM may be diagnosed at the same time as IBD , it may be diagnosed later in the course of the disease, or, more rarely, before IBD is diagnosed
Inflammatory bowel disease (IBD) consisting of Crohn's disease (CD) and ulcerative colitis (UC) may be complicated by the presence of extraintestinal manifestations (EIM)
This is a retrospective cohort study comparing the risk of IBD between D-EIM patients and age/sex matched patients without D-EIM
.
According to age, sex, body mass index, deprivation, comorbidities, smoking, use of loperamide, anemia and lower digestive tract symptoms adjusted hazard ratio (HR)
Digestion
A total of 7447 patients with D-EIM (74% women; median age 38 years) and 29,297 patients without D-EIM were included in this study
.
Among patients with D-EIM, it was observed that 131 (1.
This study confirmed that patients with D-EIM have a 6-fold increase in the risk of being diagnosed with IBD
.
Younger, smoking, low body mass index, anemia and lower digestive risks tract symptoms and an increased diagnosis of IBD
This study confirmed that patients with D-EIM have a 6-fold increase in the risk of being diagnosed with IBD
Original source:
Dominic King.
The Risk of Later Diagnosis of Inflammatory Bowel Disease in Patients With Dermatological Disorders Associated With Inflammatory Bowel Disease.
Leave a message here